Transcriptome sequencing analysis of these samples was performed to explore the molecular mechanisms governing the variation in onset time and disease severity among patients with ALD with an exon 2 deletion in the ABCD1 gene. The gene discussed is ABCD1; the disease is adrenoleukodystrophy.